M. Kelly Guyton

736 total citations
17 papers, 587 citations indexed

About

M. Kelly Guyton is a scholar working on Cell Biology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, M. Kelly Guyton has authored 17 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cell Biology, 10 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in M. Kelly Guyton's work include Calpain Protease Function and Regulation (14 papers), RNA regulation and disease (7 papers) and Nerve injury and regeneration (4 papers). M. Kelly Guyton is often cited by papers focused on Calpain Protease Function and Regulation (14 papers), RNA regulation and disease (7 papers) and Nerve injury and regeneration (4 papers). M. Kelly Guyton collaborates with scholars based in United States, Armenia and Japan. M. Kelly Guyton's co-authors include Naren L. Banik, Swapan K. Ray, Denise Matzelle, Arabinda Das, Supriti Samantaray, James C. McPherson, Eric A. Sribnick, Steven D. Zumbrun, John A. Bojescul and Varduhi H. Knaryan and has published in prestigious journals such as Annals of the New York Academy of Sciences, Neuroscience and Journal of Neurochemistry.

In The Last Decade

M. Kelly Guyton

17 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Kelly Guyton United States	13	189	176	147	129	85	17	587
Paula Hernández United States	14	195 1.0×	82 0.5×	51 0.3×	130 1.0×	47 0.6×	35	731
Shen Li China	18	315 1.7×	76 0.4×	88 0.6×	40 0.3×	101 1.2×	76	863
Guofeng Bao China	15	269 1.4×	29 0.2×	138 0.9×	132 1.0×	52 0.6×	53	748
Christos Profyris Australia	8	205 1.1×	42 0.2×	247 1.7×	280 2.2×	77 0.9×	22	910
Shota Takashima Japan	11	235 1.2×	91 0.5×	63 0.4×	29 0.2×	101 1.2×	29	573
Alan Peterson United States	9	156 0.8×	165 0.9×	117 0.8×	51 0.4×	69 0.8×	16	591
Junko Okano Japan	12	228 1.2×	31 0.2×	58 0.4×	80 0.6×	127 1.5×	28	557
Eva Holmberg Sweden	22	680 3.6×	110 0.6×	122 0.8×	92 0.7×	32 0.4×	40	1.5k
Xing Cheng China	14	220 1.2×	62 0.4×	59 0.4×	113 0.9×	34 0.4×	37	581
J. L. Underwood United States	10	219 1.2×	53 0.3×	138 0.9×	194 1.5×	55 0.6×	17	750

Countries citing papers authored by M. Kelly Guyton

Since Specialization

Citations

This map shows the geographic impact of M. Kelly Guyton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Kelly Guyton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Kelly Guyton more than expected).

Fields of papers citing papers by M. Kelly Guyton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Kelly Guyton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Kelly Guyton. The network helps show where M. Kelly Guyton may publish in the future.

Co-authorship network of co-authors of M. Kelly Guyton

This figure shows the co-authorship network connecting the top 25 collaborators of M. Kelly Guyton. A scholar is included among the top collaborators of M. Kelly Guyton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Kelly Guyton. M. Kelly Guyton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Guyton, M. Kelly, et al.. (2014). Gender and Age Differences in Growth Factor Concentrations From Platelet-Rich Plasma in Adults. Military Medicine. 179(7). 799–805. 102 indexed citations

Johnson, Peter C., et al.. (2014). Variance of matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) concentrations in activated, concentrated platelets from healthy male donors. Journal of Orthopaedic Surgery and Research. 9(1). 29–29. 13 indexed citations

Guyton, M. Kelly, Michael F. Cuenin, Steven D. Hokett, et al.. (2013). Histologic Evaluation of Osseous Regeneration Following Combination Therapy With Platelet-Rich Plasma and Bio-Oss in a Rat Calvarial Critical-Size Defect Model. Journal of Oral Implantology. 41(5). 543–549. 17 indexed citations

Park, Sook‐Young, Kenkichi Nozaki, M. Kelly Guyton, et al.. (2012). Calpain inhibition attenuated morphological and molecular changes in skeletal muscle of experimental allergic encephalomyelitis rats. Journal of Neuroscience Research. 90(11). 2134–2145. 12 indexed citations

Das, Arabinda, M. Kelly Guyton, Gerald Wallace, et al.. (2012). Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats. Journal of Neurochemistry. 124(1). 133–146. 50 indexed citations

Das, Arabinda, et al.. (2011). Calpain Inhibition Attenuates Apoptosis of Retinal Ganglion Cells in Acute Optic Neuritis. Investigative Ophthalmology & Visual Science. 52(7). 4935–4935. 24 indexed citations

Guyton, M. Kelly, Arabinda Das, Supriti Samantaray, et al.. (2010). Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis. Journal of Neuroscience Research. 88(11). 2398–2408. 43 indexed citations

Guyton, M. Kelly, Saurav Brahmachari, Arabinda Das, et al.. (2009). Inhibition of calpain attenuates encephalitogenicity of MBP‐specific T cells. Journal of Neurochemistry. 110(6). 1895–1907. 18 indexed citations

Das, Arabinda, et al.. (2008). Activation of Calpain and Caspase Pathways in Demyelination and Neurodegeneration in Animal Model of Multiple Sclerosis. CNS & Neurological Disorders - Drug Targets. 7(3). 313–320. 34 indexed citations

10.

Das, Arabinda, M. Kelly Guyton, Denise Matzelle, Swapan K. Ray, & Naren L. Banik. (2008). Time‐dependent increases in protease activities for neuronal apoptosis in spinal cords of Lewis rats during development of acute experimental autoimmune encephalomyelitis. Journal of Neuroscience Research. 86(13). 2992–3001. 33 indexed citations

11.

Samantaray, Supriti, Varduhi H. Knaryan, M. Kelly Guyton, et al.. (2007). The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats. Neuroscience. 146(2). 741–755. 79 indexed citations

12.

Guyton, M. Kelly, Azizul Haque, Arthur A. Vandenbark, et al.. (2007). Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients. Journal of Neuroimmunology. 190(1-2). 139–145. 53 indexed citations

13.

Banik, Naren L., Arabinda Das, Dena P. Garner, et al.. (2005). Mechanism of Apoptosis in Rat Retinal Ganglion Cell Line RGC–5 Involves Calpain–Mediated Proteolysis: Calpain Inhibition Provides Functional Neuroprotection. Investigative Ophthalmology & Visual Science. 46(13). 1323–1323. 1 indexed citations

14.

Guyton, M. Kelly, James Michael Wingrave, Anil Yallapragada, et al.. (2005). Upregulation of calpain correlates with increased neurodegeneration in acute experimental auto-immune encephalomyelitis. Journal of Neuroscience Research. 81(1). 53–61. 45 indexed citations

15.

Guyton, M. Kelly, Eric A. Sribnick, Swapan K. Ray, & Naren L. Banik. (2005). A Role for Calpain in Optic Neuritis. Annals of the New York Academy of Sciences. 1053(1). 48–54. 12 indexed citations

16.

Guyton, M. Kelly. (2005). A Role for Calpain in Optic Neuritis. Annals of the New York Academy of Sciences. 1053(1). 48–54. 7 indexed citations

17.

Ray, Swapan K., Denise Matzelle, Eric A. Sribnick, et al.. (2003). Calpain inhibitor prevented apoptosis and maintained transcription of proteolipid protein and myelin basic protein genes in rat spinal cord injury. Journal of Chemical Neuroanatomy. 26(2). 119–124. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact